跳转至内容
Merck
CN

72262

过氧化镍

technical, ~30% active peroxide basis

别名:

Nickel dioxide, Nickel oxide

登录 查看组织和合同定价。

选择尺寸


关于此项目

经验公式(希尔记法):
NiO2
化学文摘社编号:
分子量:
90.69
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352000
EC Number:
234-823-3
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

过氧化镍, technical, ~30% active peroxide basis

InChI key

PZFKDUMHDHEBLD-UHFFFAOYSA-N

InChI

1S/2Ni.3O

SMILES string

O=[Ni]O[Ni]=O

grade

technical

form

powder

reaction suitability

core: nickel
reagent type: catalyst
reagent type: oxidant

concentration

~30% (active peroxide)

Quality Level

正在寻找类似产品? 访问 产品对比指南

Other Notes

醇转化为酸以及腙转化为重氮烷的氧化剂

Application

Catalyst for:
  • One-dimensional oxide-metal hybrid structures and site-specific enhanced reactivity for CO oxidation
  • Microwave induced catalytic degradation of crystal violet

Used to study differences in reactivity trends for carbon monoxide catalyzed oxidation caused by anionic transition metal oxide clusters

Reagent:
  • For solvent-free oxidation of alcohols†
  • For chemoselective oxidation of organic compounds using inductive heating
  • To improve the synthesis of methoxy cephalosporin′s intermediate

signalword

Danger

Hazard Classifications

Aquatic Chronic 4 - Carc. 1A Inhalation - Ox. Sol. 2 - Skin Sens. 1 - STOT RE 1 Inhalation

存储类别

5.1B - Oxidizing hazardous materials

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Faceshields, Gloves, type P3 (EN 143) respirator cartridges


历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Javier Jiménez-Lamana et al.
Nanomaterials (Basel, Switzerland), 10(5) (2020-05-28)
Although nickel allergy and carcinogenicity are well known, their molecular mechanisms are still uncertain, thus demanding studies at the molecular level. The nickel carcinogenicity is known to be dependent on the chemical form of nickel, since only certain nickel compounds
Shadabul Haque et al.
Journal of controlled release : official journal of the Controlled Release Society, 307, 32-43 (2019-06-04)
The development of inhalable 'nanomedicines' based on biocompatible lipids and polymers is attracting increasing interest worldwide. Our understanding of how pulmonary inflammation impacts on lung distribution and clearance kinetics however, is limited. Similarly, there is limited information on how the
Robert K DeLong et al.
Nanomaterials (Basel, Switzerland), 9(12) (2019-11-28)
Currently, there is a great interest in nanoparticle-based vaccine delivery. Recent studies suggest that nanoparticles when introduced into the biological milieu are not simply passive carriers but may also contribute immunological activity themselves or of their own accord. For example
Chiara Argentati et al.
Journal of personalized medicine, 10(1) (2020-02-12)
Ex vivo cell/tissue-based models are an essential step in the workflow of pathophysiology studies, assay development, disease modeling, drug discovery, and development of personalized therapeutic strategies. For these purposes, both scientific and pharmaceutical research have adopted ex vivo stem cell
Rut Sanchis et al.
Materials (Basel, Switzerland), 12(18) (2019-09-12)
Different nickel catalysts have been tested for the transformation of levulinic acid into γ-valerolactone using an easy hydrothermal method, taking advantage of the properties of the high temperature water. A metallic nickel catalyst derived from NiO synthesized by a nanocasting

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持